RevOpsis Therapeutics
RevOpsis
Dover, United States · Founded 2022 · $18.4M raised
- Headquarters
- Dover
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- revopsis.com
- Total Funding
- $18.4M
- Last Round
- Venture RoundSep 2025
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
RevOpsis Therapeutics is a next-generation biopharmaceutical company developing multispecific antibody therapies using its proprietary Rev-Mod Platform. Its lead asset RO-104 is a trispecific biologic targeting retinal vascular diseases including neovascular age-related macular degeneration. Based in Dover, Delaware with 2-10 employees.
Summary
RevOpsis Therapeutics is a Biotech company based in Dover, United States, founded in 2022. It has raised $18.4M in total across 3 rounds, most recently a Venture Round in Sep 2025.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Sign up to see all 3 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/revopsis-therapeutics"><img src="https://indexed.vc/api/badge/company/revopsis-therapeutics" alt="RevOpsis Therapeutics on Indexed.vc" width="260" height="76" /></a>